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1. Introduction 
Although adenosine 3’,5’-monophosphate (cyclic 
AMP) has important roles in the control of cell 
proliferation and cell growth [ 11, the regulation of 
cyclic AMP synthesis in cultured cells is relatively 
unknown. In addition to classical hormones [2], E-type 
prostaglandins stimulate adenylate cyclase in a variety 
of tissues [3]. Prostaglandins can be produced by most 
mammalian cells and might thus serve as local modula- 
tors of cyclic AMP formation. This contention is sup- 
ported by our recent observation that endogenous 
prostaglandin (PG)E2 synthesis by polyoma virus trans- 
formed 3T3 fibroblasts markedly raises the cellular 
cyclic AMPlevels [4]. In this report we describe a 
stimulatory effect of arachidonic acid on cyclic AMP 
concentrations in regular 3T3 fibroblasts which is not 
mediated by PGE2. Instead, conversion to the unstable 
prostaglandin Iz appears to be involved. PGIz (prosta- 
cyclin, PGX) is a recently discovered inhibitor of 
platelet aggregation [5,6] which elevates cyclic AMP 
levels [7,8]. Although it was described as a product of 
arachidonic acid metabolism in rat stomach in 1971 
[9] the biological properties of PGIs were not revealed 
until 1976 [6]. 
Abbreviations: EMPA, 9or, 1 lorepoxymethano-lS(S)-hydroxy- 
prosta-S(cis), 13 (Irons)-dienoic acid; MEPA, 9or, 1 la-methano- 
epoxy-15(S)-hydroxyprosta-5(cis), 13 (trans)-dienoic acid; PG, 
prostaglandin 
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2. Materials and methods 
[ 1-r4C]Arachidonic acid was obtained from the 
Radiochemical Centre, Amersham, England and 
arachidonic acid from Nu Chek Prep Inc., Elysian, 
Minn., USA. PGG2 [lo] and 15-hydroperoxy-5,8,11, 
13-eicosatetraenoic acid [ 1 l] were prepared as 
described. Balb/c 3T3 mouse embryo tibroblasts 
were kindly given by Dr M. M. Burger. 9a, 1 lo- 
Epoxymethano- and 9o, 1 la-methanoepoxy-15- 
hydroxy-prosta-5, 13dienoic acid (EMPA and MEPA, 
respectively), PGD2, PGEz and PGF20 were provided 
by the Upjohn Company. Cells were cultivated in 
Dulbecco’s modified Eagle’s medium containing 10% 
calf serum [4]. Three or four days after seeding, media 
were carefully removed and the cells were rinsed with 
phosphate-buffered saline (PBS, 3 X 5 ml). After 
addition of 3 ml PBS/9 cm dish, substances to be 
tested were added in 0.6-6 d ethanol or acetone. 
Incubations were performed at 37°C. Cyclic AMP and 
DNA were determined on the same dish [4]. Platelet 
rich plasma (PRP) [ 121 was prepared as described 
before. Platelet aggregation was monitored with a 
Payton dual channel aggregometer. 
3. Results 
3.1. Effects of arachidonic acid and PGGz on cyclic 
AMP levels 
Arachidonic acid elevated cyclic AMP levels in 
3T3 fibroblasts as measured after 5 min incubations 
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Table 1 Table 2 
Effect of arachidonic acid on cyclic AMP levels Effects of PGG,, EMPA, MEPA, PGD,, PGE, and PGF,o 
on cyclic AMP levels 
Arachidonic acid (ng/ml) Cyclic AMP (pmol/pg DNA) 
Additions (kg/ml) Cyclic AMP (pmol/pg DNA) 
- 0.26 
25 0.55 
100 2.12 
250 6.97 
500 13.30 
-a 0.15 
250a 0.23 
aIndomethacin (final concentration 10s6 M) was added 5 min 
prior to the addition of arachidonic acid 
3T3 fibroblasts were incubated for 5 min at 37°C with various 
concentrations of arachidonic acid in phosphate buffered 
saline (PBS) prior to cyclic AMP analyses. The values are 
means of triplicate determinations on each of two separate 
culture dishes 
(table 1). The effect was prevented by indomethacin, 
suggesting that arachidonic acid had to be converted 
by prostaglandin endoperoxide synthase (EC 1.14.- 
99.1) [13] prior to stimulation. In agreement with 
this, PGGa elevated cyclic AMP and this effect was 
not inhibited by indomethacin (table 2). Two endo- 
peroxide analogs, EMPA and MEPA, which have 
similar biological effects as PGGz [ 141 did not raise 
cyclic AMP. This suggested that the endoperoxide 
had to be converted further to exert its effect. The 
product which mediated the effect was not PGD?, 
PGEz or PGF20 (table 2). 
None 0.21 
PGG, (0.1) 3.24 
PGG, (0.25) 11.18 
PGG, (0.25)a 12.00 
PGG, (0.5) 19.19 
EMPA 0.19 
MEPA (I) 0.15 
PGD, (1) 0.19 
PGE, (1) 0.23 
PGF:,,(l) 0.20 
aIndomethacin (final concentration IO-’ M) was added 5 min 
prior to the addition of PGG, 
3T3 cells were incubated for 5 min at 37°C with various 
compounds in PBS prior to cyclic AMP analyses. The values 
are means of triplicate determinations on each of two separate 
culture dishes 
3.2. Conversion of arachidonic acid to 6-keto 
PGF, Cr 
[l-‘4C]Arachidonic acid (55 Ci’/mol, 3 pg in 3 ml 
PBS/9 cm plate) was incubated at 37°C for 5 min with 
3T3 tibroblasts. The PBS was removed and mixed with 
5 vol. ethanol. After dilution with water and diethyl 
ether extraction at pH 3 products were analyzed by 
thin-layer radiochromatography (solvent system: 
organic phase of ethyl acetate/acetic acid/2,2,4_trimeth- 
ylpentane/water, 9: 2: 5: 10 v/v/v/v). 40% of the radio- 
activity had the same R, (0.95) as arachidonic acid. 
The remainder had been converted to more polar 
compounds. The major product (40% of the radio- 
activity) cochromatographed with PGEz (RF 0.30), 
one product (7% of the radioactivity, R, 0.88) moved 
immediately behind arachidonic acid and another 
product (5% of the radioactivity, R, 0.12) moved 
behind PGF,o(R, 0.20). This latter compound 
chromatographed in the same region as reported 
for 6-keto PGFio [6]. The products were converted 
to methyl ester, methoxime-trimethylsilyl derivatives 
and analysed by gas-liquid radiochromatography and 
by gas-liquid chromatography/mass spectrometry. 
Five radioactive compounds had the following C-values: 
19.2, 21.3, 23.8, 24.3 and 25.2 on 1% SE-30. The 
third and fourth compounds had mass spectra identical 
to those of the syn- and anti-isomers of PGEz methyl 
ester, 0methoxime-di-O-trimethylsilyl derivative, 
except that all ions containing the carboxyl group 
were shifted 2 m.u. upwards by the r4C-label. The 
mass spectrum of the component with the longest 
retention time showed ions at m/e 600, 560,541, 510, 
470,45 1,420 and 380 corresponding to M-l 5, M-3 1, 
M-71, M-90, M-90-3 1, M-90-71, M-2 X 90, M-2 X 90-3 1 
and M-2 X 90-71-31 of 6-keto-[1-14C] PGFro methyl 
ester, O-methoxime-tri-0trimethylsilyl derivative [ 151. 
3.3. Formation of an inhibitor of platelet aggregation 
3T3 tibroblasts were incubated with 3 ml PBS 
containing arachidonic acid (7 pg/mI) or PGGz 
(2 pg/ml). At different times after the addition, 50 d 
of the buffer was removed and immediately added 
together with 120 pg arachidonic acid to 0.5 ml PRP. 
416 
Volume 8 1. number 2 FEBS LETTERS September 1977 
Aliquots removed within I min inhibited platelet aggre- 
gation. Maximal inhibition (SO-100%) was observed 
3-6 min after the addition whereas aliquots removed 
later than 12 min had no inhibitory effect. These 
results show that 3T3 fibroblasts produce a factor 
which has the characteristics of PGI? on platelet aggre- 
gation [6]. 
3.4. Inhibition of the effects of arachidonic acid and 
PGGz on cyclic AMP levels 
It has been reported that 15hydroperoxy-5, 8, 11, 
13-eicosatetraenoic acid inhibits the conversion of 
PGGz to PGIz [ 161. Therefore 3T3 cells were preincu- 
bated for 15 s with 15hydroperoxy-5, 8, 11, 13-eicosa- 
tetraenoic acid (9 &ml) prior to the addition of 
arachidonic acid (250 ng/ml) or PGGz (250 ng/ml) 
(table 3). The stimulatory effect of either compound 
was completely inhibited, indicating that conversion 
to PGIz was involved. 
4. Discussion 
Arachidonic acid elevated cyclic AMP levels in 3T3 
fibroblasts. Inhibition of the effect by indomethacin 
suggested that transformation to PGGa, PGHz or a 
prostaglandin endoperoxide metabolite was required. 
Although the cells efficiently converted arachidonic 
acid to PGEZ, this prostaglandin had no effect on 
cyclic AMP levels. Neither did PGDs, a potent 
stimulator of platelet adenylate cyclase [ 171, PGF20, 
Table 3 
Inhibition of the effects of arachidonic acid and PGG, 
on cyclic AMP levels 
Additions Cyclic AMP (pmol/wg DNA) 
None 0.19 
15-OOH20:4 0.10 
20 : 4 8.89 
20:4+15-OOH20:4 0.13 
PGG, 11.18 
PGG, +,lS-OOH20:4 0.17 
15-Hydroperoxy-5,8,11,13-eicosatetraenoic ac d( 15 - OOH 
20 : 4,9 &ml) was added to 3T3 cultures 15 s prior to the 
addition of arachidonic acid (250 &ml) or PGG, (250 &ml). 
5 min later the cells were analyzed for cyclic AMP. The values 
are means of triplicate determinations on each of two separate 
culture dishes 
Arrchidonlc acid e 
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Fig.1. Arachidonic acid transformations and effects on cyclic 
AMP levels in 3T3 fibroblasts. 
nor the endoperoxide analogs EMPA and MEPA. 
Incubations of arachidonic acid with 3T3 cells showed 
that in addition to PGEz and PGF20, 6-keto PGFro 
was formed. The latter compound is derived from 
arachidonic acid as outlined in fig.1. Two enzymes 
are required for the transformation: prostaglandin 
endoperoxide synthase which forms PGHs from 
arachidonic acid and PGH + PGI isomerase. These 
enzymes are inhibited by indomethacin [ 131 and 
15-hydroperoxy-5, 8, 10, 13-eicosatetraenoic acid [16], 
respectively. In addition to arachidonic acid, PGGz 
and 13-dehydro PGIz methyl ester [ 181 raised cyclic 
AMP levels in 3T3 fibroblasts. On a molar basis 13- 
dehydro PGIz methyl ester was twice as potent 
as arachidonic acid in raising cyclic AMP levels. 
Indomethacin prevented the effect of arachidonic acid 
but not that of PGG2, whereas 15-hydroperoxy-5,8,11, 
13.eicosatetraenoic acid also inhibited the effect of 
PGG2. These results suggest hat the novel prostaglandin 
endoperoxide metabolite, PG12, has significance as a 
modulator of cyclic AMP concentrations in 3T3 
fibroblasts. 
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It has recently been reported that arachidonic acicl 
elevates cyclic AMP levels in epithelial cells [ 191 and 
in human synovial fibroblasts [20]. Since these effects 
on cyclic AMP could not be readily explained by 
conversion to PGEz it is possible that PGI:! formation 
is involved also in these cells. 
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